Cardinal Health, Inc. (CAH) Accused of Misleading Shareholders According to the complaint, in March 2015, Cardinal announced its plan to acquire Cordis, a medical device manufacturer, touting that the acquisition

Just Energy Group Inc. (JE) Accused of Improper Accounting Practices According to the complaint, for alleged violations of the Securities Exchange Act of 1934 between November 9, 2017 and July

Is the Proposed Acquisition Best for Genomic Health (GHDX) and Its Shareholders? Robbins LLP’s investigation focuses on whether the board of directors at Genomic Health is undertaking a fair process

Teladoc Health, Inc.’s (TDOC) Officers and Directors Accused of Failing to Disclose Conduct Violations to Investors According to the complaint, Teladoc’s executives allowed multiple violations that hurt the company, including

Cloudera, Inc. (CLDR) Accused of Misleading Shareholders According to the derivative complaint, from 2015-2017, Cloudera touted its 140% revenue increase and earned recognition as one of the largest global enterprises.

Oasmia Pharmaceutical AB (OASM) Accused of Improper Related-Party Transactions According to the complaint, for alleged violations of the Securities Exchange Act of 1934 between October 23, 2015 and July 9,

GTT Communications, Inc. (GTT) Accused of Misleading Investors According to the complaint, for alleged violations of the Securities Exchange Act of 1934 between February 26, 2018 and July 1, 2019,

Robbins LLP is Investigating the Officers and Directors of National Beverage Corp. (FIZZ) on behalf of Shareholders Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors

Aclaris Therapeutics, Inc. (ACRS) Accused of Making Misleading Claims in Video Advertisement According to the complaint for alleged violations of the Securities Exchange Act of 1934 between May 8, 2018